Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
*** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines…